Pfizer: all 4,072 studies
Page 27 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy VolunteersCompletedNCT02058277Phase 1
- A Study of ARRY-371797 in Patients With LMNA-Related Dilated CardiomyopathyCompletedNCT02057341Phase 2
- A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking MetforminTerminatedNCT02053116Phase 2
- A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking MetforminTerminatedNCT02053103Phase 2
- A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.CompletedNCT02052726Phase 1
- MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic FunctionTerminatedNCT02050815Phase 1
- Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted ConditionsCompletedNCT02041273Phase 1
- A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)CompletedNCT02031991Phase 1
- A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast CancerCompletedNCT02025192Phase 1
- A Study Evaluating The Safety Of PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-06)CompletedNCT02015156Phase 1
- Efficacy, Safety And Tolerability Study In Subjects With Parkinson's DiseaseCompletedNCT02006290Phase 1
- A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule FormulationCompletedNCT02006277Phase 1
- A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377CompletedNCT02005991Phase 1
- Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult SubjectsCompletedNCT01994668Phase 1
- A Single Dose Study Of PF-06678552 In Healthy SubjectsCompletedNCT01992614Phase 1
- A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple MyelomaCompletedNCT01989325Phase 2
- A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast CancerCompletedNCT01983501Phase 1
- A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751CompletedNCT01981694Phase 1
- A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy SubjectsCompletedNCT01981681Phase 1
- A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy AdultsTerminatedNCT01981499Phase 1
- A Study Of The Safety, Tolerability, And Pharmacokinetics Of Multiple Doses Of PF-05180999 In Healthy AdultsWithdrawnNCT01981486Phase 1
- Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid TumorsCompletedNCT01978964Phase 1
- A Safety Study of SGN-LIV1A in Breast Cancer PatientsCompletedNCT01969643Phase 1
- A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult VolunteersCompletedNCT01959594Phase 1
- A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)CompletedNCT01953731Phase 1
- A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865CompletedNCT01951144Phase 1
- Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin AmericaWithdrawnNCT01938144Phase 3
- A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)CompletedNCT01934738Phase 1
- Drug-Drug Interaction Study With PF-05089771CompletedNCT01934569Phase 1
- A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804WithdrawnNCT01924650Phase 1
- A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese SubjectsCompletedNCT01920399Phase 1
- A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male VolunteersCompletedNCT01918202Phase 1
- Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)CompletedNCT01918176Phase 1
- A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562CompletedNCT01914796Phase 1
- A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market ProductCompletedNCT01906125Phase 1
- Characterization Of The Effect Of Food On Palbociclib (PD-0332991) AbsorptionCompletedNCT01904747Phase 1
- A Safety Study of SGN-CD33A in AML PatientsCompletedNCT01902329Phase 1
- Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational AgeCompletedNCT01897753
- A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy VolunteersCompletedNCT01897142Phase 1
- A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy SubjectsCompletedNCT01893866Phase 1
- Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)CompletedNCT01870986Phase 1
- A Study to Investigate the Effect of PH-797804 on QTc IntervalCompletedNCT01862887Phase 1
- Relative Bioavailability With PF-05089771 Capsule Versus Oral DispersionCompletedNCT01854996Phase 1
- A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)CompletedNCT01844804Phase 1
- A Study In Healthy Volunteers To Estimate The Effect Of The Active Ingredient Particle Size And Percentage Of The Excipients Used To Formulate The Capsules In The Dissolution Rate Of The Formulations In The Gastrointestinal TractCompletedNCT01844323Phase 1
- Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care SettingTerminatedNCT01838057
- First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese SubjectsCompletedNCT01835197Phase 1
- A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid UsersCompletedNCT01825447Phase 1
- A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet FormulationCompletedNCT01821079Phase 1
- A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male VolunteersCompletedNCT01821066Phase 1
- A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy SubjectsCompletedNCT01812538Phase 1
- Cold Pressor Test is Used in This Study to Assess the Effect of PF-06305591 on Pain Intensity Evoked by Cold in Healthy Male SubjectsCompletedNCT01812265Phase 1
- Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in TurkeyCompletedNCT01810861
- Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedNCT01807377Phase 1
- A Study Comparing the Plasma Drug Exposure of an Oral Dose of Palbociclib (PD-0332991) to an Intravenous Dose of Palbociclib (PD-0332991)CompletedNCT01802476Phase 1
- Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic FlareCompletedNCT01797796Phase 1
- A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy VolunteersCompletedNCT01796327Phase 1
- Single Dose Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 In Healthy Adult SubjectsCompletedNCT01794364Phase 1
- A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy VolunteersCompletedNCT01789528Phase 1
- Study Of Remission In Patients Treated For Generalized Anxiety DisorderCompletedNCT01788553
- Study Evaluating the Association of Antibiotic Measures and Control of Bacterial ResistanceCompletedNCT01788449
- Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in FinlandTerminatedNCT01787565
- RIPT of Ibuprofen Topical GelCompletedNCT01787448Phase 1
- A Safety Study of SGN-CD19A for B-Cell LymphomaCompletedNCT01786135Phase 1
- A Safety Study of SGN-CD19A for Leukemia and LymphomaCompletedNCT01786096Phase 1
- A Post Marketing Surveillance As Required By Philippine Food And Drug AdministrationWithdrawnNCT01781442
- Safety and Tolerability Study of Multiple Doses of PF-06305591CompletedNCT01776619Phase 1
- Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male VolunteersCompletedNCT01776437Phase 1
- A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)CompletedNCT01775761Phase 1
- Safety And Tolerability Study Of BID Titration Scheme With PF-05089771CompletedNCT01772264Phase 1
- Ibuprofen 5% Topical Gel CIPTCompletedNCT01771822Phase 1
- Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedNCT01757756Phase 1
- Fecal Recovery of the Probiotic Bacteria Lactobacillus Rhamnosus GG (LGG) and Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) in Healthy Humans Following Daily Consumption of a Probiotic SupplementCompletedNCT01757054Phase 4
- A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.CompletedNCT01756781Phase 1
- A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] Palbociclib (PD-0332991) In Healthy Male VolunteersCompletedNCT01756768Phase 1
- Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy AdultsCompletedNCT01753791Phase 1
- Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug LevelsCompletedNCT01749085Phase 1
- Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female SubjectsCompletedNCT01747941Phase 1
- A Study To Assess The Safety Of PF-06342674 In Healthy VolunteersCompletedNCT01740609Phase 1
- A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy VolunteersCompletedNCT01731327Phase 1
- A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic SubjectsCompletedNCT01720537Phase 1
- A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy AdultsCompletedNCT01707082Phase 1
- A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed StateCompletedNCT01706796Phase 1
- Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 YearsCompletedNCT01706367Phase 1
- Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)CompletedNCT01702506Phase 1
- Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily PracticeCompletedNCT01692899
- A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In ChinaCompletedNCT01692886Phase 3
- A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162CompletedNCT01691274Phase 1
- Benzonatate Dose Tolerance StudyCompletedNCT01690975Phase 1
- A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted StateCompletedNCT01690351Phase 1
- A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell CarcinomaTerminatedNCT01677390Phase 1
- A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy VolunteersCompletedNCT01677065
- Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release FormulationCompletedNCT01677039Phase 1
- A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.CompletedNCT01672645Phase 1
- A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy SubjectsCompletedNCT01664065Phase 1
- Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast CancerWithdrawnNCT01658176Phase 2
- Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy VolunteersCompletedNCT01655511Phase 1
- A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal CancerCompletedNCT01649336Phase 1
- Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 YearsCompletedNCT01643941Phase 1
- A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy VolunteersCompletedNCT01637285Phase 1